top of page
0
HOME
RESEARCH NOTE (payable)
BLOG POSTS
ABOUT
CONTACT
CETX
More
Use tab to navigate through the menu items.
Log In
Profile
Join date: Nov 11, 2021
Posts
Oct 21, 2022
∙
12 min
The $10 billion dollar unicorn in INmune Bio: on fast-progressors in AD, APOE4, TREM2 and EMACC
Summary APOE4, involved in different mechanisms in the brain including lipid homeostasis, is the strongest risk factor for Alzheimer’s...
542
0
3
Sep 23, 2022
∙
12 min
The $10 Billion unicorn in INmune Bio: the potential of XPro in Parkinson’s
Summary The evolution of the treatment failures for Parkinson’s disease has striking similarities with Alzheimer’s. Just like in...
538
0
8
Sep 2, 2022
∙
8 min
The FDA’s two leaps at once: on fast approval pathways and neurofilament light
Summary Neurofilament Light (NfL) is potentially the most important biomarker in neurodegenerative diseases. The FDA’s AdCom validated...
580
0
4
Load More
Carl Kestens
Admin
3
Followers
0
Following
Follow
Following icon
More actions
Profile
Blog Posts
Blog Comments
Blog Likes
bottom of page
